The conversion of IDH1 R132C to IDH1 R132F and the acquired isoform mutation of IDH2 R172V have been reported in patients with IDH1-mutated cholangiocarcinoma who develop resistance to ivosidenib as a result [44,45]. This evidence concerns the gene IDH2 and cholangiocarcinoma.